HYPR - NASDAQ

Hyperfine, Inc.

HYPR·NASDAQ

$1.53

+4.1%

HealthcareMedical - Devices

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$129.27M

EPS-0.4300

P/E Ratio-3.57

Earnings Date08/12/2026

hypr

Shares Outstanding

Last Annual Value

94.20M

3-Year CAGR

10%

5-Year CAGR

30%

10-Year CAGR

35%

Adjust for Inflation

Hyperfine, Inc. Competitors Analysis of shares-outstanding

HYPR · NASDAQ

Company	shares-outstanding	CAGR 3Y	CAGR 5Y	CAGR 10Y
Hyperfine, Inc. NASDAQ:HYPR	94.20M	9.7%	6.0%	N/A
FONAR Corporation NASDAQ:FONR	6.55M	-1.1%	-0.6%	-0.0%
LENSAR, Inc. NASDAQ:LNSR	11.96M	2.9%	5.0%	N/A
MaxCyte, Inc. NASDAQ:MXCT	106.43M	1.0%	3.3%	12.2%
Owlet, Inc. NYSE:OWLT	562.50M	308.1%	134.8%	N/A
Rapid Micro Biosystems, Inc. NASDAQ:RPID	44.68M	1.3%	1.5%	N/A
Sight Sciences, Inc. NASDAQ:SGHT	52.15M	2.4%	1.9%	N/A
TriSalus Life Sciences, Inc. NASDAQ:TLSI	37.90M	12.7%	3.9%	N/A
Quince Therapeutics, Inc. NASDAQ:QNCX	43.26M	5.1%	7.8%	N/A
Vivani Medical, Inc. NASDAQ:VANI	62.39M	7.1%	11.5%	27.4%
AVITA Medical, Inc. NASDAQ:RCEL	27.86M	3.2%	2.7%	15.3%

Hyperfine, Inc. Fair Value Envelope

HYPR · NASDAQ

Our analysis suggests that HYPR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.535, this represents a potential HIDDEN relative to our calculated worth for Hyperfine, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.535

Related Guides

Blog Categories

Continue your HYPR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.